scPharmaceuticals Inc. - Common Stock (SCPH)

Historical Holders from Q4 2017 to Q3 2025

Symbol
SCPH
CUSIP
810648105
Type / Class
Equity / Common Stock
Shares outstanding
53.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
41M
Holdings value
$232M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
108
Number of buys
67
Number of sells
-52
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of scPharmaceuticals Inc. - Common Stock (SCPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Weiss Asset Management LP 5.4% $16.3M 2.88M Weiss Asset Management LP Sep 30, 2025
GLAZER CAPITAL, LLC 4.64% $6.19M 2.47M Glazer Capital, LLC Sep 2, 2025
KING LUTHER CAPITAL MANAGEMENT CORP 4% -42.9% $12M -$8.67M 2.13M -42% Luther King Capital Management Corporation Sep 30, 2025

Institutional Holders of scPharmaceuticals Inc. - Common Stock (SCPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 41M $232M +$31.4M $5.67 108
2025 Q2 38.2M $146M +$3.42M $3.81 95
2025 Q1 37.5M $98.7M -$7.79M $2.63 87
2024 Q4 39.8M $141M +$5.28M $3.54 84
2024 Q3 37.3M $170M +$42.7M $4.56 93
2024 Q2 27.8M $121M +$4.5M $4.35 77
2024 Q1 26.7M $134M -$7.69M $5.02 76
2023 Q4 11.8K $73.7K $6.27 1
2023 Q3 29.9M $213M +$9.11M $7.12 73
2023 Q2 28.5M $291M +$40.8M $10.19 81
2023 Q1 24.6M $223M +$13.3M $9.07 63
2022 Q4 21.4M $154M +$53.7M $7.17 59
2022 Q3 14M $91.3M -$10.1M $6.52 38
2022 Q2 15.7M $75.9M -$3.64M $4.82 37
2022 Q1 15.9M $90.1M -$1.16M $5.68 34
2021 Q4 15.9M $80M -$1.6M $5.02 29
2021 Q3 16.2M $108M +$1.49M $6.65 30
2021 Q2 16M $97.9M -$7.16M $6.11 35
2021 Q1 17.2M $114M +$1.44M $6.65 45
2020 Q4 16.3M $86.3M -$6.51M $5.29 45
2020 Q3 17.1M $127M -$2.88M $7.45 48
2020 Q2 17.5M $129M +$36.7M $7.36 49
2020 Q1 12.5M $92.4M +$10.2M $7.40 32
2019 Q4 11.1M $62.7M +$1.61M $5.66 26
2019 Q3 7.58M $44.5M +$1.47M $5.89 24
2019 Q2 7.37M $23.5M -$277K $3.19 27
2019 Q1 7.48M $22.5M -$1.27M $3.00 32
2018 Q4 7.85M $29.5M -$769K $3.76 31
2018 Q3 8.05M $47.2M -$121K $5.87 30
2018 Q2 8.09M $45.8M -$6.15M $5.66 36
2018 Q1 8.32M $103M +$6.69M $12.40 37
2017 Q4 7.8M $94.1M +$94.1M $12.09 23